Pharmacy 543 Pharmacy Laws & Ethics MIDTERM EXAMINATION October 27, 2008
|
|
|
- Miranda Wright
- 10 years ago
- Views:
Transcription
1 Pharmacy 543 Pharmacy Laws & Ethics MIDTERM EXAMINATION October 27, 2008 Name: Last First Student Number Questions 1-30 are multiple choice. Please record your answers on Side 2 of a Standard Answer Sheet, Form Follow the instructions on Side 1. Carefully complete your name and student number (both characters and bubbles). Select the BEST answer from the available choices. Multiple choice, one point each 30 points. Questions are short-answer, 10 points. Ethics question, 10 points. Exam total: 50 points. Legibility: please verify that your written answers can be read by mere mortals, and your name and student ID number are legible, correct, and present on any papers you turn in. Please double-check your student ID number for accuracy. Errors or omissions may delay or impact your grade. Turn in: (1) the Standard Answer Form, (2) your answers to the short answer questions (1 sheet 2 sides) and the ethics question (1 sheet 2 sides) (3) other pages as necessary (see below). Please DO NOT turn in pages that do NOT need to be graded. You may NOT ask questions during the exam. However, if you believe that a question is technically flawed, please circle the faulty question number and briefly describe your concern. Turn in that (those) exam page(s) and your concerns will be addressed. So as to NOT confuse you, terms like NOT, TRUE, FALSE are presented in BOLD, ALL-CAPS. MULTIPLE CHOICE QUESTIONS 1. The role of the administrative branch of federal or state government is to: a. Enact the law b. Interpret the law c. Implement the law d. Formulate the law 2. The Tenth Amendment to the Constitution gives the states the right to legislate in all areas except those specifically prohibited or given to the US Congress in the Constitution. Which of the following is a PERMITTED state legislative activity? a. Regulate interstate commerce b. Regulate healthcare professions c. Raise armies d. Coin money Page 1 of 10
2 3. Common law is: I. A tradition derived from Napoleonic Law in France II. Applicable throughout the United States III. Relies on precedent in establishing a standard for future decisions d. I, II and III 4. *Were you to violate a rule in the practice of pharmacy, you could be involved in which of the following proceedings? I. Criminal II. Civil III. Administrative d. I, II and III 5. Which is TRUE about federal and state laws when they are in conflict? I. Federal laws prevail when permitted in the Constitution II. State laws always prevail III. State laws prevail if more restrictive c. III only d. I and III only e. I, II and III 6. The powers of Washington s Board of Pharmacy include promulgation of rules for all EXCEPT: a. Wholesaling of drugs and medical devices by pharmacists b. Establish criteria for valid prescriptions c. Distribution of drugs and medical devices by physicians d. Establish the qualifications for licensure of pharmacists or pharmacy interns 7. Which of the following is required to be registered with the Drug Enforcement Administration in order to participate in the manufacture, prescribing or dispensing of controlled substances? I. Pharmacists II. Pharmacy Technicians III. Pharmacies c. I and III d. I, II, and III Page 2 of 10
3 Name: Last First Student Number 8. When the Administrator of the DEA has proposed to revoke the DEA registration of a pharmacy, who has the burden of proof that this pharmacy should no longer have the registration? a. The DEA b. The pharmacy 9. Which DEA registrants are required to provide the following security measures to protect their controlled substances: alarms, perimeter security, locked cages? a. Wholesalers b. Pharmacies c. Narcotic Treatment Programs d. Physicians 10. On 12/31/2008 you find that you are running out of pharmacy storage space for prescriptions so you decide to shred some of your older controlled substance prescriptions. The DEA would have NO reason to object if you destroyed all prescriptions that had been written earlier than which of the following dates? a. 12/31/07 b. 06/30/07 c. 12/31/06 d. 06/30/ When performing your required DEA inventory, for which of the following must you record an exact count? a. Oxycodone 5 mg/apap 325 mg (C-II) b. Hydrocodone 10 mg/apap 650 mg (C-III) c. Tylenol Elixir with Codeine 12 mg/5ml (C-V) d. Diazepam 10 mg (C-IV) 12. When the DEA schedules a drug that was previously NOT designated as a controlled substance, when is a pharmacy required to inventory the supply of this drug that it has in stock? a. On the day that the DEA scheduled the drug. b. Within 30 days of the date of the DEA's action. c. Within 60 days of the date of the DEA's action. d. Within 90 days of the date of the DEA's action. 13. You receive a prescription for Hydrocodone 10 mg/apap 650 mg tablets No. 30. (C-III) You have only 15 tablets in stock. How much time do you have to supply the remaining 15 tablets? a. 3 days b. 5 days c. 7 days d. 180 days Page 3 of 10
4 14. You send a DEA Form 222 to a wholesaler to order drugs but the company does not have one of the requested items in current stock. How long does the wholesaler have to supply this drug? a. 3 days b. 7 days c. 30 days d. 60 days 15. Which of the following is a valid DEA number for Dr. Evelyn Johnson, pediatrician. a. AJ b. MJ c. AJ d. AE Which federal official has the authority to define, by rule, an "emergency situation" as this term is used in the Controlled Substances Act? a. The Attorney General b. The Secretary of Health & Human Services c. The DEA Administrator d. The U. S. Surgeon General 17. Which of the following is a requirement for a pharmacist to be able to legally fill a verbal prescription for a Schedule II drug? I. Immediate administration of the drug is necessary II. No alternative treatment is available III. It is not reasonably possible for the prescriber to provide a written prescription c. I and III d. I, II, and III 18. In which of the following medical conditions is it legal to prescribe a Schedule II stimulant drug in Washington State? a. Narcolepsy b. Cerebral Palsy c. A.I.D.S. d. Glaucoma 19. A hard copy prescription for a controlled substance must contain all of the following EXCEPT: a. The prescriber's address b. Date of issue c. The symbols C-II, C-III, C-IV or C-V d. The prescriber's DEA number 20. Which of the following is NOT a Schedule III drug? a. Hydrocodone 5mg with Acetaminophen 325 mg tablets b. Marinol (dronabinol) capsules c. Testosterone 10 mg tablets d. Valium (diazepam) 5 mg tablets Page 4 of 10
5 Name: Last First Student Number 21. Which of the following practitioners are considered to be EXEMPT from registration by the DEA? I. A physician in the U. S. Army II. An Advanced Registered Nurse Practitioner employed by an Indian Tribe III. A dentist in the U. S. Public Health Service d. I, II, and III 22. You have dispensed the following prescription calling for Hydrocodone 5 mg and Acetaminophen 325 mg tablets, No. 60, Refill 3 times, Sig: Take 1 tablet every 4 hours as needed for pain. (C-III) Assuming that you dispensed 60 tablets originally, how many times, prior to the expiration of the prescription, may you dispense partial refills if you dispensed 30 tablets with each subsequent refill. a. 2 times b. 4 times c. 6 times total = 180; 180/30=6 d. 8 times 23. A prescriber FAXed a prescription to your pharmacy for Morphine Sulfate Tablets sustained release 10 mg, No. 100, Sig: Take 1 tablet every 12 hours for pain. The prescription is for a hospice patient. You are allowed to fill the prescription as follows: a. Only a 72-hour emergency supply may be dispensed b. Only a 7 day supply may be dispensed c. Only 21 day supply may be dispensed d. The full quantity may be dispensed 24. The three ethical principles for conducting behavioral research established by the Belmont Report were: a. Respect for persons, virtue and trust b. Beneficence, justice and trust c. Respect for persons, beneficence, justice d. Beneficence, justice and virtue 25. Justice, in the context of biomedical ethics, refers to: a. Making decisions that are fair to the patient b. Ensuring the fair distribution of society s goods c. Ensuring equal distribution of society s goods d. Doing things in accordance with existing law Page 5 of 10
6 26. When would it be OK to administer an experimental therapy to a patient WITHOUT her/his consent? I. The health care provider believes that the patient would refuse therapy if the therapy s potential adverse events were disclosed II. The therapy to be provided represents standard of care III. The patient is unconscious and failure to treat would lead to serious harm d. I, II and III 27. To whom of the following could prescription information NOT be provided WITHOUT a patient s authorization? a. Medical personnel treating an immediate, life-threatening condition b. An FDA investigator exploring drug manufacturing problems c. A county sheriff d. A researcher operating under an approved Institutional Review Board protocol 28. A Board of Pharmacy investigator presents her credentials and asks to be admitted to the pharmacy to review specified prescription records. What should you do? a. Stall the investigator until your attorney arrives b. Admit the investigator c. Request to see a search warrant d. Request to see consent forms for the specified prescription records 29. If the Board of Pharmacy promulgated a rule prohibiting physicians from dispensing controlled substances and the rule was challenged by physicians, which of the following reasons might a judge give for overturning the rule? I. The Board had exceeded its statutory authority II. The Board had made an error of law III. The Board made a procedural error d. I, II and III 30. Which of the following are required for compliance with Washington rules when compounding a commercially available prescription drug? I. Authorization by the prescriber II. Ingredients are listed in an official compendium III. Patient agrees d. I, II and III Page 6 of 10
7 Name: Last First Student Number Short Answer Questions. Answers written outside the provided space will not be graded. 31. Susan Morrison comes to your pharmacy requesting that you fill a prescription for her that she's received previously from a different pharmacy. As the RECEIVING pharmacist, please fill in the missing items on the transferred prescription below for a non-controlled substance prescription. (2 points) Susan Morrison Today's date: 10/27/2008 TRANSFER Synthroid 25 mcg #30 Sig: Take one tablet by mouth once daily Dr. Jack Chen Issue date of original prescription: 8/15/ refills on original prescription Originally dispensed on 8/30/2008 Transferor Pharmacist: Mike Cheadle 153 First Avenue Seattle, WA DEA number: MC Number of remaining refills \ Date and location(s) of all refills 32. Your colleague at the pharmacy is confused about what protected health information (PHI) she can disclose to another person without the patient's prior authorization. Help her by giving her two examples of situations where it is permissible to use and disclose PHI under applicable HIPAA rules. (2 points) a. Treatment \ payment \ health care operations b. 33. A state passed a law to the effect that a pharmacist could refill a Schedule II prescription two times when the patient requires continual use of the medication. (A) Would you comply with the state law? (B) Explain the legal principle that supports your decision. (2 points) a. No, Federal law doesn't permit refills (1 pt) b. Doctrine of preemption (1 pt) unless state law is more restrictive, which it isn't in this case (1 pt) Page 7 of 10
8 34. Please complete the following table with the list of the remaining four classes of prescription medications and their respective time limits / expirations in Washington. Follow the example provided. (2 points) Prescription Medication Class Schedule II Schedule III Schedule IV Schedule V Legend drug Washington Time Limit / Expiration 12 months 6 months 6 months 12 months 12 months 35. Mary Johnson is a patient who you've been seeing in your pharmacy for several years. She enters your pharmacy and hands you a new prescription. You notice that the prescriber has written for oxycodone 10mg, which you do not have available in your pharmacy - you only stock the 5mg strength. You also notice another error on the prescription. Please update the prescription below according to what is allowed for a pharmacist to change on a Schedule II controlled substance prescription. You may also indicate if something is incorrect that you cannot change (2 points, ½ point will be deducted for each incorrect recommendation) Patient name: Mary Johnson Patient DOB: 4/24/1956 Patient address: 2868 Oak St. Seattle, WA Date: 10/27/2008 Oxycodone 10mg #30 Sig: I tablet PO Q4hrs PRN pain Refill: 2 Dr. Keith Monroe (signature) DEA # AM Madison Ave. Seattle, WA Change strength to 5 mg, quantity to 60 and sig to 2 tablets; eliminate refills Page 8 of 10
9 Name: Last First Student Number Ethics Question. Answers written outside the provided space will not be graded. Evaluate issues of pharmacy practice law regarding the following, abstracted from a January 2008 news release from the US Food and Drug Administration. (2) The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency. FDA is concerned that unfounded claims like these mislead women and health care professionals. The pharmacy operations improperly claim that their drugs, which contain hormones such as estrogen, progesterone, and estriol (which is not a component of an FDA-approved drug and has not been proven safe and effective for any use) are superior to FDA-approved menopausal hormone therapy drugs and prevent or treat serious diseases, including Alzheimer's disease, stroke, and various forms of cancer. FDA is concerned that the claims for safety, effectiveness, and superiority that these pharmacy operations are making mislead patients, as well as doctors and other health care professionals. Compounded drugs are not reviewed by the FDA for safety and effectiveness, and FDA encourages patients to use FDA-approved drugs whenever possible. The warning letters state that the pharmacy operations violate federal law by making false and misleading claims about their hormone therapy drugs... The pharmacy operations compound hormone therapy drugs that contain estriol as well as progesterone and estrogen. No drug product containing estriol has been approved by FDA and the safety and effectiveness of estriol is unknown... FDA also responded today to a citizen petition from Wyeth, Madison, NJ, asking FDA to take regulatory action against compounding pharmacy operations that produce compounded "BHRT" drugs. Other stakeholders, including health care providers and consumer groups, have also raised concerns about "BHRT" drugs... confined to WA s practice act and associated rules would it be OK if there was a valid prescriber-patient-pharmacist relationship? (Yes) advertising restrictions in WA compendial status of ingredients adequate drug compounding controls Evaluate the ethical considerations for preparing the medication given the circumstances above. inside the box. (8 points) Stay Describe the dilemma Perspective Beneficence Page 9 of 10
10 Nonmaleficence Autonomy Justice Virtue Root Cause Page 10 of 10
Donald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules
D. E. A. Rules 21 C.F.R. 1300 Everything that you need to know but were afraid to ask DEA Rules - Objectives The student will be able to discuss the manner in which the DEA regulates the distribution of
PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED
PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED Senate Bill 92 (as enacted) PUBLIC ACT 285 of 2014 Sponsor: Senator Mike Green Senate Committee: Regulatory Reform House Committee: Health Policy
ANALYSIS AS REPORTED FROM COMMITTEE
PHARMACY TECHNICIAN LICENSURE S.B. 92 (S-5): ANALYSIS AS REPORTED FROM COMMITTEE Senate Bill 92 (Substitute S-5 as reported by the Committee of the Whole) (as passed by the Senate) Sponsor: Senator Mike
Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility. 2009 DEA Audits. Scheduled/Controlled Drugs
Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility Nancy Lamb RPh Good Day Pharmacy DEA- Drug Enforcement Administration This is not the State Health Department
REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH
REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS ACTIVITY DESCRIPTION This program will assist pharmacy technicians to understand the
NH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
Narcotic Treatment Programs
This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act
What Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
How To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 12 13 To amend Chapter 34 of Title 43 of the Official Code
ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:
ARKANSAS PRODUCTS: Any product containing ephedrine, pseudoephedrine, or phenylpropanolamine or any of their salts, isomers, or salts of isomers, alone or in a mixture. (A.C.A. 5-64-212) PRODUCT EXEMPTIONS:
Keweenaw Holistic Family Medicine Patient Registration Form
Keweenaw Holistic Family Medicine Patient Registration Form How did you first learn of our Clinic? Circle one: Attended Lecture Internet KHFM website Newspaper Sign in window Yellow Pages Physician Friend
Patient access to medical records
New Law Alert No. 11 April 2002 California edition Patient access to medical records Acupuncture treatment modalities are expanded Cervical cancer screening CME required for pain management Mental health
Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents
Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility
EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015
Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the
Drug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this
WASHINGTON LAWS, 1987
ensure compliance with this chapter and the treatment standard authorized by this chapter. A methadone treatment center shall not have a caseload in excess of three hundred fifty persons. The caseload
Professional Roles in Nursing Practice. Legal and Ethical Principles and Values
Professional Roles in Nursing Practice Legal and Ethical Principles and Values Introduction Professional nursing has expanded rapidly within the past few years to include increased expertise, specialization,
Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication
POLICY SOMERSET COUNTY BOARD OF EDUCATION 1. PURPOSE Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication Number: 600-32 Date
2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC
2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC Objectives 1. Review the changes to the pharmacy practice act related to sterile compounding. 2. Understand the role of the
2010-2011 Prescription Drug Monitoring Program Annual Report
2010-2011 Prescription Drug Monitoring Program Annual Report Prescription Drug Monitoring Program E-FORCSE 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 X 3700 December 1, 2011 Prescription
ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS
Medical Examiners Chapter 540-X-8 ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS 540-X-8-.01 540-X-8-.02 540-X-8-.03
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee)
GEORGIA ~ STATUTE STATUTE DATE Enacted 1972 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq;
Topics in Pharmacy Technician and Intern Laws for Ohio Pharmacists
Topics in Pharmacy Technician and Intern Laws for Ohio Pharmacists By: Donald L. Sullivan, R.Ph., Ph.D. Program Number: 036-367-10-001-H03 C.E.U.s: 0.1 Contact Hours: 1 hour Release Date: 02/23/2010 Expiration
Table of Contents. 2 P a g e
Table of Contents Introduction... 3 Important Contact Information... 3 Pharmacy Rights... 3 Claims Adjudication... 3 Reversals... 4 Required Data Fields... 4 Identification cards... 4 Required Identification
Pharmacy Program Pre-Test
Last Name: Pharmacy Program Pre-Test * For each question, put a check mark for the one option that you think is correct. 1. A pharmacist receives a security prescription from a known local medical group
COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS
Rule 400 3 CCR 713-7 COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS BASIS. The authority for promulgation of Rule 400 ( these Rules ) by the Colorado
COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS (PAs) INTRODUCTION
Rule 400 3 CCR 713-7 COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS (PAs) INTRODUCTION BASIS. The authority for promulgation of Rule 400 ( these Rules
SPECIAL USE AUTHORIZATION APPLICATION (Instructions to Applicants)
Mail To: P.O. Box 8935 Ship To: 1400 E. Washington Avenue Madison, WI 53708-8935 Madison, WI 53703 FAX #: (608) 261-7083 E-Mail: [email protected] Phone #: (608) 266-2112 Website: http://dsps.wi.gov CONTROLLED
OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program
Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department
13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 To amend Chapter 34 of Title 43 of the Official Code of
RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS
RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS CHAPTER 540-X-18 QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) FOR CERTIFIED REGISTERED NURSE PRACTITIONERS (CRNP) AND CERTIFIED
Strategies for Electronic Exchange of Substance Abuse Treatment Records
Strategies for Electronic Exchange of Substance Abuse Treatment Records Patricia Gray, J. D., LL. M. Prepared for the Texas Health and Human Services Commission and the Texas Health Services Authority
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: April 2015 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
11 MEDICATION MANAGEMENT
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
- 1 - First Time Pharmacy Managers (Revised 02/02/2011)
State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO
Patient Information Form Trinity Wellness Center. Insurance Information
Patient Information Form Trinity Wellness Center Last Name, First Name, MI* Date of Birth* / / Social Security # -- -- Sex* : Female / Male Student Status (circle one): Full-time / Part-time / not a student
AMERICAN PSYCHOLOGICAL ASSOCIATION
A. Definitions AMERICAN PSYCHOLOGICAL ASSOCIATION MODEL LEGISLATION FOR PRESCRIPTIVE AUTHORITY Approved by APA Council of Representatives, 2009 (1) Board means the {state psychology licensing board}. (2)
Prescribing Standards for Nurse Practitioners (NPs)
Prescribing Standards for Nurse Practitioners (NPs) July 2014 Approved by the College and Association of Registered Nurses of Alberta Provincial Council, (July 2014) Permission to reproduce this document
CHAPTER 101 (HB 500)
AN ACT relating to crime victims. CHAPTER 101 1 CHAPTER 101 (HB 500) Be it enacted by the General Assembly of the Commonwealth of Kentucky: Section 1. KRS 216B.400 is amended to read as follows: (1) Where
State of Utah Department of Commerce Division of Occupational and Professional Licensing
State of Utah Department of Commerce Division of Occupational and Professional Licensing Official Use Only Number: Date Approved/Denied: Approved/Denied By: Retired Volunteer Health Care Practitioner APPLICANT
Investigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: October 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.
CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. Direct supervision means that a licensed pharmacist
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS
ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05 610-X-5-.06 610-X-5-.07
DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY
DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY Remote Pharmacy Owner Name: DBA Name: Address: Telephone Number: Fax Number:
Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy
Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Legislative changes PDMP program changes 503B outsourcing facilities Rules changes Ph800 review Ph300 Ph400 Ph700 Current issues
RADIOGRAPHER LICENSE AND LIMITED X-RAY MACHINE OPERATOR PERMIT
STATE OF WISCONSIN Department of Regulation & Licensing 1400 E Washington Ave PO Box 8935 Madison WI 53708-8935 Governor Scott Walker Secretary Dave Ross Email: [email protected] Web: www.drl.wi.gov Voice:
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:
Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain
32-1921. Exempted acts; exemption from registration fees; definition
AZ AT Act 32-1921. Exempted acts; exemption from registration fees; definition A. This chapter does not prevent: 1. The prescription and dispensing of drugs or prescription medications by a registered
ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes
ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes # scored items 1. Regulations and Pharmacy Duties 35 A. Overview of technician
REGISTERED NURSE ANESTHETIST APPLICATION
ALASKA BOARD OF NURSING DEPARTMENT OF COMMERCE, COMMUNITY, AND ECONOMIC DEVELOPMENT DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL LICENSING 550 WEST 7 TH AVENUE, SUITE 1500 ANCHORAGE, ALASKA 99501
Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs
Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Charlesworth Rae, BS, PharmD, JD Investigational Drug Pharmacist July 2012 1 Outline of Presentation I. Introduction
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:
Commonwealth of Massachusetts Department of Public Health, Office of Prescription Monitoring and Drug Control 99 Chauncy Street, Boston, MA 02111 Tel: 617-753-7310 Email: [email protected] MA ONLINE
Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists
Chapter 17. Institutional Pharmacy Louisiana Administrative Code Title 46 Professional and Occupational Standards Subchapter A. General Requirements Part LIII: Pharmacists 1701. Cross References A. For
Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations
North Carolina Board of Pharmacy Controlled Substance Pocketcard A brief summary of pertinent rules and regulations impacting the practice of pharmacy ~ Controlled II Substance Controlled II Substance
CURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
CHAPTER 131. SENATE BILL No. 33
CHAPTER 131 SENATE BILL No. 33 AN ACT concerning the state board of pharmacy; pharmacy technicians; terms and membership of the state board of pharmacy; fingerprinting and criminal history record checks;
REGULATION 3 PHARMACY TECHNICIANS
REGULATION 3 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS (a) Pharmacy technician means those individuals, exclusive of pharmacy interns, who assist
RULES AND REGULATIONS FOR LICENSING DOCTORS OF ACUPUNCTURE AND ACUPUNCTURE ASSISTANTS (R5-37.2-ACU)
RULES AND REGULATIONS FOR LICENSING DOCTORS OF ACUPUNCTURE AND ACUPUNCTURE ASSISTANTS (R5-37.2-ACU) STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS Department of Health July 1980 As Amended: March 1988
CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS
I. INTRODUCTION CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS Advance registered nurse practitioners (ARNPs) and clinical nurse practitioners (CNPs) have their scope
Healthcare Math: Calculating Dosage
Healthcare Math: Calculating Dosage Industry: Healthcare Content Area: Mathematics Core Topics: Applying medical abbreviations to math problems, using formulas, solving algebraic equations Objective: Students
Methadone Maintenance Treatment for Opioid Dependence
COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO P O L I C Y S TAT E M E N T # 2 1 0 Methadone Maintenance Treatment for Opioid Dependence APPROVED BY COUNCIL: PUBLICATION DATE: KEY WORDS: REFERENCE MATERIALS:
Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010
Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an
IACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013
Exempt Sections within the Food, Drug, and Cosmetic Act If a "traditional compounder", defined as a licensed pharmacist or licensed physician, meets ALL conditions within Section 503A, the compounder is
TEXAS ~ STATUTE Continued
TEXAS ~ STATUTE STATUTE DATE Enacted 1981 REGULATORY BODY Texas Rev. Civ. Stat., Occupations Code, Chapter 204: Physician Assistant Licensing Act; Occupations Code Chapter 157; Authority of Physician to
(PLEASE TYPE OR PRINT IN INK) PART I - ALL APPLICANTS MUST COMPLETE:
APPLICATION FOR PARAMEDICS, EMT S, NURSE PRACTITIONERS, AMBULANCE SERVICES AND PHYSICIANS AND SURGEONS ASSISTANTS PROFESSIONAL LIABILITY INSURANCE (Claims Made Basis) APPLICANT S INSTRUCTIONS: 1. Answer
NOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures.
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER NARCOTICS AND CONTROLLED DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
UW School of Dentistry Comprehensive Medication Policy
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
AMERICAN NATIONAL INSURANCE COMPANY CREDIT INSURANCE DIVISION P. O. BOX 696785 * SAN ANTONIO, TEXAS 78269-6785 800-899-6502
P. O. BOX 696785 * SAN ANTONIO, TEXAS 78269-6785 DISABILITY CLAIM FORM INSTRUCTIONS Enclosed is a claim form required in order to process disability payments on your loan. It is important that all questions
Chapter 57 Respiratory Care Practices Act
Chapter 57 Respiratory Care Practices Act 58-57-1 Short title. This chapter is known as the "Respiratory Care Practices Act." Enacted by Chapter 208, 1990 General Session 58-57-2 Definitions. In addition
House Study Bill 503 - Introduced
House Study Bill 0 - Introduced HOUSE FILE BY (PROPOSED COMMITTEE ON HUMAN RESOURCES BILL BY CHAIRPERSON MILLER) A BILL FOR An Act relating to prescription authority for certain psychologists and making
Information for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
ADOPTED REGULATION OF THE BOARD OF OCCUPATIONAL THERAPY. LCB File No. R017-14. Effective October 24, 2014
ADOPTED REGULATION OF THE BOARD OF OCCUPATIONAL THERAPY LCB File No. R017-14 Effective October 24, 2014 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted.
Chapter 11 The Practice of Physician Assistants
Chapter 11 The Practice of Physician Assistants Scope 100 The following regulations pertain to physician assistants practicing medicine with physician supervision. Physician assistants may perform those
U.S. Bureau of Labor Statistics. Pharmacy Tech
From the: U.S. Bureau of Labor Statistics Pharmacy Tech Pharmacy technicians fill prescriptions and check inventory. Pharmacy technicians help licensed pharmacists dispense prescription medication. They
Prescriptive Authority Frequently Asked Questions Mandated by Senate Bill 406
Agenda Item: 7.7 Prepared by J Zych Meeting Date: January 23-24, 2014 Prescriptive Authority Frequently Asked Questions Mandated by Senate Bill 406 Summary of Request: This agenda item is for information
Pharmacy Law Overview. From Civil Liability to Criminal Prosecution
Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 [email protected] Pharmacy
CONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual
State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program User Support Manual Contents 1 What Is a Requestor?... 3 2 Registration... 4 2.1 Registration Process... 4 2.2 Registering as
